Search Results

You searched for : LatestNewsonCOVIDTreatment  

	RedHill Biopharma Announces Positive Top-Line Safety and Efficacy Data from Phase 2 COVID-19 Study of Opaganib Preliminary data from the non-powered U.S. Phase 2 study of 40 hospitalized patients shows that orally-administered opaganib was safe, with no material ... Jan 02
	The RedHill Phase II / III candidate opaganib reduces ARDS-related blood clotting in the preclinical model in COVID-19 patients The results also show that opaganib inhibits SARS-CoV-2 virus replication and proinflammatory markers in relevant preclinical models ... Dec 17
	Incyte announces results of phase 3 RUXCOVID study of Ruxolitinib as a treatment for patients with COVID-19 associated cytokine storm The data will be further analyzed to determine any potential impact on other studies of ruxolitinib in patients with COVID-19, and will be submitted ... Dec 15
	PureTech starts phase 2 trial of LYT-100 in long COVID-19 respiratory complications and related sequelae PureTech’s global, randomized, double-blind, placebo-controlled Phase 2 trial is designed to evaluate the efficacy, safety and tolerability of LYT-100 in adults ... Dec 05
	Zydus receives approval from DCGI to commence Phase III clinical trials with Pegylated Interferon alpha-2b in India Zydus Cadila, had received an approval from the Drugs Controller General of India to start the Phase 3 clinical trial in COVID-19 patients with ... Dec 04
	Roche receives USFDA emergency use authorization for new test to measure the level of SARS-CoV-2 antibodies This test may help identify recovering patients who could potentially be serum and plasma donors for developing treatments for COVID-19... Dec 03
	ARCA biopharma receives U.S. FDA fast track designation for AB201 as a potential treatment for COVID-19 ARCA believes that AB201 is the only anticoagulant class new chemical entity in development for COVID-19 that has a Fast Track designation... Nov 24
	AbCellera-discovered antibody granted interim authorization by health Canada as a treatment for COVID-19 Bamlanivimab received emergency use authorization (EUA) from the U.S. Food and Drug Administration on November 9, 2020... Nov 23
	RedHill announces DSMB unanimous recommendation to continue COVID-19 opaganib phase 2/3 study The independent, pre-programmed DSMB unanimously recommends the continuation of the global Phase 2/3 study of orally administered opaganib in severe COVID-19 pneumonia... Nov 23
	Regeneron's REGEN-COV2 is first antibody cocktail for COVID-19 to receive US FDA emergency use authorization The clinical evidence from Regeneron's outpatient trial suggests that monoclonal antibodies such as REGEN-COV2 have the greatest benefit when given early after diagnosis ... Nov 23
	India's indigenous solution to COVID-19 in progress Monoclonal antibody leads for COVID-19: A way forward In combating COVID-19 ... Nov 19
	Fluvoxamine an antidepressant drug may help prevent severe COVID-19 Researchers say, fluvoxamine may be having beneficial effects by some other mechanism not yet understood... Nov 17
	Eli Lilly's bamlanivimab receives US FDA clearance for the treatment of COVID-19 Eli Lilly’s neutralizing antibody bamlanivimab receives US FDA emergency use authorization for the treatment of recently diagnosed COVID-19... Nov 12
	Celltrion Launches CT-P59, an antibody preventive treatment for COVID-19 Celltrion launches post-exposure prophylaxis clinical trial of anti-COVID-19 monoclonal antibody treatment candidate, CT-P59 ... Oct 15
14 Matching result(s) found!

Trending Now
	Breast Cancer Early Warning Signs: What Every Woman in India Needs to KnowJuly 16, 2026
	HbA1c Test Explained: What It Measures, Normal Range, and Why It Matters for IndiansJuly 16, 2026
	Not Just Weight Loss: How Bariatric Surgery Improves Diabetes, PCOS, and Thyroid-Related Health ChallengesJuly 15, 2026
	Leiutis Pharmaceuticals announces CDSCO approval for Global-First Synthetic CBD Therapy for Mild to Moderate Anxiety DisordersJuly 15, 2026
	Dr Agarwals Institute of Optometry and SASTRA University Jointly Launch Optometry ProgrammeJuly 15, 2026
	SIMS Hospital Treats Spinal Compression in 84-Year-Old with Pacemaker Through Single-Incision Endoscopic SurgeryJuly 15, 2026
	Apollo Hospitals Secunderabad Successfully Treats Achalasia Cardia Patients with Advanced POEM ProcedureJuly 15, 2026
	Happiest Health Announces Entry into Healthcare Publishing BusinessJuly 15, 2026
	Indian Stroke Association Expands ‘Save the Brain’ Campaign with Stroke 360° Scientific Conference in SalemJuly 15, 2026
	Milann Successfully Overcomes a Hidden Fertility Barrier: Chronic Endometritis Diagnosed and Treated, Leading to Successful IVF PregnancyJuly 15, 2026
	Forus Health Launches FH eyepal, a Connected Digital Eye Clinic Designed to Expand Access to Comprehensive Eye CareJuly 15, 2026
	Adult ADHD Diagnostics: Why Evaluations Are Rising Later in LifeJuly 15, 2026
	Healthcare Apps Changing Patient Care: How Digital Health Tools Are Reshaping India's Healthcare LandscapeJuly 15, 2026
	How Stress Affects Physical Health: Understanding the Body's Response and What You Can Do About ItJuly 15, 2026
	Pediatric Immunity: Realities of Seasonal Vaccines & DevelopmentJuly 14, 2026
	Hormonal Imbalances in Women: PCOS and Perimenopause July 14, 2026
	Erectile Dysfunction and Overall Health: Why It Is a Signal, Not Just a SymptomJuly 14, 2026
	PCOS and Fertility Connection: What Every Woman Trying to Conceive Should KnowJuly 14, 2026
	Prostate Health for Indian Men: Screening, Symptoms, and CareJuly 13, 2026
	Polycystic Kidney Disease: Symptoms, Diagnosis, and ManagementJuly 13, 2026